Refine Search

  •  
  •  
Big Movers in the Stock Market

...that were moving substantially or trading heavily Monday on the New York Stock Exchange and Nasdaq Stock Market. NYSE Aventis SA, down $5.76 at $74.00 The French drug maker agreed to be bought by its smaller rival Sanofi-Synthelabo for about...

http://chronicle.augusta.com/stories/2004/04/27/fin_413588.shtml
Finance
Merger announcements drive stocks higher

...dollar strengthened, hurting commodities prices. Stocks got an early boost Monday after French drug maker Sanofi-Aventis SA announced plans to buy U.S. health care products company Chattem Inc. for $1.9 billion, while mining equipment...

http://chronicle.augusta.com/stories/2009/12/22/bus_560391.shtml
Business
Generic Plavix launched

...probe was opened into possible antitrust activity surrounding Plavix. Bristol-Myers and its marketing partner Sanofi-Aventis SA, which sells Plavix outside the United States, say their patent has been infringed, and are exploring legal and commercial...

http://chronicle.augusta.com/stories/2006/08/09/bus_91912.shtml
Business
'Super pill' might also fight drug abuse

...it could fight both obesity and smoking, two of humanity's biggest killers. The French pharmaceutical firm Sanofi Aventis SA plans to seek federal approval for rimonabant next year. But the drug's benefits may go beyond just smokers and obese...

http://chronicle.augusta.com/stories/2004/11/15/liv_434470.shtml
Life & style
Study shows Plavix a risk for returning ulcers

...Southwestern Medical School and Veterans Affairs hospital in Dallas. Plavix is aggressively marketed on TV by Sanofi-Aventis SA and Bristol-Myers Squibb Co. It was the 12th best-selling prescription drug in the United States in 2003, with...

http://chronicle.augusta.com/stories/2005/01/20/liv_440411.shtml
Life & style
Drug companies seek lawsuit protection

...won't do it without indemnification," said Len Lavenda, a spokesman for Sanofi Pasteur, the vaccine arm of Sanofi-Aventis SA. But some insist immunizing drug companies won't be enough to spark interest in a field fraught with an uncertain...

http://chronicle.augusta.com/stories/2005/12/12/bus_31785.shtml
Business | Swine flu
Drug combination increases risk of heart attack

...College of Cardiology conference whose organizers issued an "expression of concern" saying the drug's maker, Sanofi-Aventis SA, told some stock analysts the results of the study in advance, in violation of the conference's embargo policies...

http://chronicle.augusta.com/stories/2006/03/14/liv_69633.shtml
Life & style
Business briefs

...AG says a merger makes sense PARIS - Swiss drug giant Novartis AG said Tuesday that a white knight bid for France's Aventis SA would make sense - but only if the French government changed its "negative attitude" toward the merger. Novartis said...

http://chronicle.augusta.com/stories/2004/03/24/bus_409765.shtml
Business | E-Z-Go
biz bits

...after deathsTOKYO --- Japan has temporarily stopped using vaccines from U.S. drugmaker Pfizer Inc. and Sanofi-Aventis SA of France while it investigates the deaths of four children who were inoculated, the health ministry said Monday.The...

http://chronicle.augusta.com/news/business/biz-bits/2011-03-07/biz-bits
Biz Bits | Business
Deals seen as welcome sign of recovery's strength

...stock. Last month, French drug maker Sanofi-Synthelabo SA unveiled a $60.2 billion hostile bid for larger rival Aventis SA - a combination that would create the world's third-largest pharmaceuticals company, behind U.S. giant Pfizer...

http://chronicle.augusta.com/stories/2004/02/16/fin_404760.shtml
Finance